Cristiana Campa
Technical R&D Advisor and Fellow at GSK
with more than 20 years experience in biologics and related analytical and development strategies, gained in different universities and companies. She joined Novartis Vaccines in 2006, focusing on the development, validation, and transfer of analytical methods for several vaccine products, first as a senior manager and then as Head of Analytical Development, Italy. Since 2012, Cristiana has worked on Quality by Design (QbD) principles implementation for vaccines. After the acquisition of Novartis Vaccines by GSK in 2015, she has been the Head of QbD Integration and, until June 2018, the Head of Science and Development Practices in Technical R&D, covering QbD implementation, Knowledge Management and Development roadmaps. In her current role, Cristiana is very active in CMC advocacy, with contributions to the cross-company discussion on innovative technologies and development strategies, fostering dialogue with Regulatory Agencies.


